A new patent application for IRLAB’s drug candidate IRL752 has been published by World Intellectual Property Organization, WIPO
IRLAB announced today that the World Intellectual Property Organization, WIPO, has published a new patent application for the drug candidate IRL752. The patent application regards a new substance patent, ‘composition of matter patent’ which, if granted in the forthcoming national application phases, may extend the market exclusivity of IRL752 by up to 10 years in relation to today’s patent protection. In connection with the publication of IRLAB’s patent application, WIPO also published an International Search Report (ISR) and a patentability statement, Written Opinion (WO).Today, the drug